Company Overview of Ovamed GmbH
Ovamed GmbH specializes in the development of treatments using biological organisms. It owns license to produce and commercialize Helminthic therapy, a biological approach to treat autoimmune diseases, such as Crohn`s disease and Ulcerative colitis. The company was formerly known as Biocure GmbH and changed its name to Ovamed GmbH in 2004. Ovamed GmbH was founded in 2003 and is based in Barsbüttel, Germany.
Founded in 2003
49 40 67 50 95 0
49 40 67 50 95 59
Key Executives for Ovamed GmbH
Similar Private Companies By Industry
|4 Animals AlsterScience GmbH||Europe|
|Acousia Therapeutics GmbH||Europe|
|Across Barriers GmbH||Europe|
|Actinodrug Pharmaceuticals GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Ovamed GmbH, please visit www.ovamed.org. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.